|
Addgene inc
pdonr221 entry vector Pdonr221 Entry Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)+Laccase2+MCS+Exon+Vector+(Plasmid+%2369893)/pmc07545072-66-7-21 Average 96 stars, based on 1 article reviews
pdonr221 entry vector - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
gateway compatible attl1 attr5 cbe entry vector pypq266a Gateway Compatible Attl1 Attr5 Cbe Entry Vector Pypq266a, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/Flag-NHR2%2BR+pcDNA3%2E1+(Plasmid+%2317317)/pmc08882796-225-0-11 Average 92 stars, based on 1 article reviews
gateway compatible attl1 attr5 cbe entry vector pypq266a - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Addgene inc
pentr d topo entry vector Pentr D Topo Entry Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pENTR_D-TOPO-GFP+(Plasmid+%2389286)/10__1186_slash_1471___213x___10___106-78-30-37 Average 90 stars, based on 1 article reviews
pentr d topo entry vector - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Addgene inc
grna entry vector ![]() Grna Entry Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)+CircRNA+Mini+Vector+(Plasmid+%2360648)/pmc08553336-238-1-21 Average 96 stars, based on 1 article reviews
grna entry vector - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
entry vector pdonr221 ![]() Entry Vector Pdonr221, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)+-+Hyperactive+AID+-+T7+RNA+Polymerase+-UGI+-+T2A+-+tdTamato+(Plasmid+%23138610)/bio_rxiv__2020__07__06__190538-184-15-18 Average 92 stars, based on 1 article reviews
entry vector pdonr221 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Addgene inc
ribosome entry site ires gfp vector ![]() Ribosome Entry Site Ires Gfp Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)IRES+GFP+(Plasmid+%2351406)/pmc06260062-69-31-37 Average 93 stars, based on 1 article reviews
ribosome entry site ires gfp vector - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Addgene inc
pcdna3 1 based plasmid ![]() Pcdna3 1 Based Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)+ZKSCAN1+MCS+Exon+Vector+(Plasmid+%2369901)/bio_rxiv__2023__09__05__556368-261-29-36 Average 96 stars, based on 1 article reviews
pcdna3 1 based plasmid - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
pcdna3 1 kras ![]() Pcdna3 1 Kras, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)-ExRai-AKAR-Kras+(Plasmid+%23118408)/pmc07746698-166-7-41 Average 91 stars, based on 1 article reviews
pcdna3 1 kras - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Addgene inc
pcdna 3 1 ![]() Pcdna 3 1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1(%2B)%2FCUG-nLuc-3XFLAG-PEST+(Plasmid+%23127313)/pm28238652-477-22-31 Average 90 stars, based on 1 article reviews
pcdna 3 1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Addgene inc
pcdna3 1 vector ![]() Pcdna3 1 Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1-FLAG-SBP-STAG2+(WT)+(Plasmid+%2373963)/pmc05902600-126-13-18 Average 88 stars, based on 1 article reviews
pcdna3 1 vector - by Bioz Stars,
2026-11
88/100 stars
|
Buy from Supplier |
|
Becton Dickinson
srpx2 cdna pcdna3.1 vector ![]() Srpx2 Cdna Pcdna3.1 Vector, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcdna3/pm19065654-32-3-15 Average 90 stars, based on 1 article reviews
srpx2 cdna pcdna3.1 vector - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Addgene inc
pcdna3 1 myc ![]() Pcdna3 1 Myc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pcdna3+1+entry+vector/pcDNA3%2E1+myc+his+Su(fu)+(CT%23768)+(Plasmid+%2313855)/pmc09376625-75-17-67 Average 93 stars, based on 1 article reviews
pcdna3 1 myc - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: eLife
Article Title: A functional genetic toolbox for human tissue-derived organoids
doi: 10.7554/eLife.67886
Figure Lengend Snippet: ( a ) Schematic of the Organoid Easytag workflow. ssRNP and a circular plasmid repair template are nucleofected into dissociated cells at day 0. By day 3, cells have proliferated to become tiny colonies and are removed from the Matrigel and dissociated for selection by flow cytometry. EGFP + cells are re-plated sparsely (~1000–1500 cells/well of a 24-well plate) and grown until day 15 when organoids reach a sufficient size to be manually picked under a fluorescent microscope. Typically, 10–40 organoid colonies formed per ~1000 cells seeded. Organoids are picked into individual wells and passaged until sufficient cells are obtained for both genotyping and freezing down the line. Cells with red nuclei represent incorrectly targeted cells. Cells with white nuclei denote correctly targeted cells. ( b ) Schematic of repair template design for N terminal fusion mEGFP-ACTB gene targeting and the final product. Arrow shows the position of gRNA. E1, exon 1; E2, exon 2; 5′HA, 5′ homology arm; 3′HA, 3′ homology arm. ( c ) Representative flow cytometry results showing the percentage of EGFP cells 72 hr after nucleofection is performed. ( d ) Representative image showing mEGFP-ACTB organoid. DIC channel on the left and EGFP channel on the right. ( e ) Immunofluorescence of mEGFP-ACTB organoids. Blue: DAPI (nuclei); green: EGFP (ACTB fusion protein); red: SOX9 (lung progenitor marker). ( f ) Schematic of the AAVS1 targeting repair template design and the final product. E1, exon 1, E2, exon 2. Arrow indicates the position of the gRNA. ( g ) Immunofluorescence of AAVS1-EF1a-mTagRFP-T organoids. Blue: DAPI (nuclei); red: mTagRFP-T (membrane localised reporter); white: SOX2 (lung progenitor marker). Scale bars in all panels denote 50 μm.
Article Snippet: The
Techniques: Plasmid Preparation, Selection, Flow Cytometry, Microscopy, Immunofluorescence, Marker, Membrane
Journal: eLife
Article Title: A functional genetic toolbox for human tissue-derived organoids
doi: 10.7554/eLife.67886
Figure Lengend Snippet: ( a ) Strategy for targeting transcriptionally silent genes using the Organoid Easytag workflow. First step: knocking-in to the 3’ end of the locus an exogenous EF1a promoter, which is flanked by two Rox sites, driving nuclear-localised Venus expression. A T2A peptide sequence is inserted before the EF1a promoter in order to minimise the influence of the future fluorescent reporter on the gene of interest (GOI). Second step: transient transfection of a plasmid encoding the Dre-recombinase to remove the exogenous EF1a promoter. This results in Venus expression becoming dependent on transcription of the targeted locus. ( b ) Schematic of the SFTPC locus repair template design and final product. E5, exon 5; 5’ HA, 5’ homology arm; 3’ HA, 3’ homology arm. Arrow indicates the position of the gRNA. Red bar indicates the position of the stop codon. ( c ) Representative images showing SFTPC-T2A-Rox-EF1a-Rox-Venus-NLS organoids before and after Dre recombinase expression. Upper panel: nuclear-localised Venus fluorescence can be observed under a standard epifluorescent microscope before Dre recombinase expression; bottom panel: Venus fluorescent signal is lost after Dre recombinase expression. Arrows indicate nuclear-localised Venus signal. ( d ) Schematic of the strategy for testing SFTPC reporter function by NKX2-1 overexpression. SFTPC reporter lines were dissociated and transduced with NKX2-1 conditional overexpression lentivirus. Transduced cells are marked by TagRFP expression which can be enriched via flow cytometry. TagRFP expression is coupled to tet3G which, upon doxycycline (Dox) administration, binds to the tetON promoter and drives NKX2-1 overexpression. ( e ) Representative immunofluorescence showing that the SFTPC reporter is functional. Blue: DAPI (nuclei); green: Venus (SFTPC reporter); white: proSFTPC protein. ( f ) Western blot against Venus in the SFTPC reporter revealed a higher molecular weight (MW) band than expected. The expected MW for proSFTPC and Venus are 21 kDa and 27 kDa, respectively, the size of higher MW band (40–50 kDa) correlated well with the predicted size of a fusion protein (~48 kDa), suggesting an inefficient T2A cleavage.
Article Snippet: The
Techniques: Expressing, Sequencing, Transfection, Plasmid Preparation, Fluorescence, Microscopy, Over Expression, Transduction, Flow Cytometry, Immunofluorescence, Functional Assay, Western Blot, Molecular Weight
Journal: eLife
Article Title: A functional genetic toolbox for human tissue-derived organoids
doi: 10.7554/eLife.67886
Figure Lengend Snippet: ( a ) Schematic of the TP63 locus repair template design and final product. E14, exon 14; 5’ HA, 5’ homology arm; 3’ HA, 3’ homology arm. Arrow indicates the position of the gRNA. ( b ) Representative images showing TP63-T2A-Rox-EF1a-Rox-Venus-NLS heterozygous organoid. Nuclear-localised Venus fluorescence can be observed under epifluorescent microscope. Scale bar indicates 50 μm. ( c ) Schematic of the TP63 genotyping strategy. 5’ and 3’ junction amplicons consist of a primer inside the Venus sequence and another primer upstream, or downstream, of the homology arm, respectively. The expected lengths of each amplicon are labelled below the schematic. ( d ) Representative gel image showing correct colony genotyping results. The WT bands were excised for Sanger sequencing in lane #3. ( e ) Schematic of the final TP63 reporter genotyping strategy to validate EF1a removal. ( f ) Representative gel image showing correct colony genotyping results after Dre recombinase.
Article Snippet: The
Techniques: Fluorescence, Microscopy, Sequencing, Amplification
Journal: Endocrinology
Article Title: Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary
doi: 10.1210/en.2018-00587
Figure Lengend Snippet: Impact of lineage-enriched transcription factors on expression of markers genes in Pit-1/Triple cells. Pit-1/Triple cells (5) were transfected with expression constructs encoding each noted transcription factor linked by an IRES to a GFP reporter open reading frame (see “Materials and Methods”). Transfected cells were isolated by GFP FACS and their RNA content was assayed for specific marker gene expression by qRT-PCR. (A) Nupr1. (B) Rxrg. (C) Nr4a2. (D) Pou4f1. In all assays, expression of the recombinant transcription factor was confirmed by targeted qRT-PCR (data not shown). Gene expression was normalized to an internal Gapdh control, and the fold change over empty vector controls was calculated using the ΔΔCt method (see “Materials and Methods”). Gapdh expression levels were stable across all assayed conditions, with no significant changes in Gapdh expression in any of the transfected samples. Error bars indicate 1 SD. n = 5 for all experiments. *P < 0.05, by t test.
Article Snippet: Cell transfection assays The cDNA of Nupr1 was amplified from mouse pituitary cDNA. cDNAs for the other studied transcription factors were obtained from OriGene or Addgene and subcloned into an internal
Techniques: Expressing, Transfection, Construct, Isolation, Marker, Gene Expression, Quantitative RT-PCR, Recombinant, Control, Plasmid Preparation
Journal: Endocrinology
Article Title: Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary
doi: 10.1210/en.2018-00587
Figure Lengend Snippet: NR4A2 acts in conjunction with POU1F1 at the Prl promoter to enhance Prl expression. (A) Schematic of the mPrl gene promoter indicating the relative positions of known POU1F1 binding sites [blue ovals (15)] as well as predicted binding sites for NR4A2 (red ovals) (identified by JASPAR). (B) NR4A2 ChIP. Pit-1/Triple cells were transfected with an expression vector encoding NR4A2, and chromatin isolated from GFP+ cells (as in Fig. 4) was assayed by NR4A2 ChIP. Levels of transcription factor occupancy at specific sites within the Prl promoter were quantified by qRT-PCR of immunoprecipitated samples. Parallel controls included quantitation of occupancy at the Gh promoter and assessment of binding in regions 500 bp upstream and downstream of the Prl promoter. The MyoD promoter served as a negative control in all studies. (C) Schematic of the mPrl gene promoter indicating the relative positioning of known POU1F1 binding sites (blue ovals) as well as predicted binding sites for POU4F1 (green ovals) (identified by JASPAR). (D) POU4F1 ChIP. Pit-1/Triple cells were transfected with an expression vector encoding POU4F1 and chromatin isolated from GFP+ cells [as in (B)] was assayed by ChIP. The Pou4f1 enhancer was assayed in this study as a positive control for the POU4F1 ChIP. (E) Nr4a2 ChIP performed in FACS-sorted mouse lactotropes. (F) Impact of NR4A2 on expression of markers genes in Pit-1/0 cells. Pit-1/0 cells were transfected with expression vectors encoding Pou1f1, Nr4a2, or both linked by IRES to GFP, and GFP+ cells were collected by FACS. qRT-PCR analysis was performed to measure changes in mRNA expression of somatotrope and lactotrope marker genes. n = 3 for all experiments. *P < 0.05; **P < 0.01; ***P < 0.001.
Article Snippet: Cell transfection assays The cDNA of Nupr1 was amplified from mouse pituitary cDNA. cDNAs for the other studied transcription factors were obtained from OriGene or Addgene and subcloned into an internal
Techniques: Expressing, Binding Assay, Transfection, Plasmid Preparation, Isolation, Quantitative RT-PCR, Immunoprecipitation, Quantitation Assay, Negative Control, Positive Control, Marker
Journal: Endocrinology
Article Title: Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary
doi: 10.1210/en.2018-00587
Figure Lengend Snippet: ChIP of POU1F1 in Pit-1/Triple cells expressing Nr4a2 vs Pit-1/Triple cells that do not express Nr4a2. Pit-1/Triple cells, which do not express Nr4a2, were transfected with the same Nr4a2-IRES-GFP plasmid used in assays presented in Fig. 4C, and control cells were transfected with the empty IRES-GFP vector. GFP+ cells were sorted by FACS, chromatin was isolated, and ChIP was performed using an antibody that recognizes POU1F1. Following immunoprecipitation, qRT-PCR was used to measure the relative levels of POU1F1 binding in Pit-1/Triple cells that had been transfected with Nr4a2 plasmid (+Nr4a2), as well as those transfected with empty vector. Immunoprecipitations using IgG served as a negative control. *P < 0.05.
Article Snippet: Cell transfection assays The cDNA of Nupr1 was amplified from mouse pituitary cDNA. cDNAs for the other studied transcription factors were obtained from OriGene or Addgene and subcloned into an internal
Techniques: Expressing, Transfection, Plasmid Preparation, Control, Isolation, Immunoprecipitation, Quantitative RT-PCR, Binding Assay, Negative Control
Journal: Endocrinology
Article Title: Transcriptome Analyses of Female Somatotropes and Lactotropes Reveal Novel Regulators of Cell Identity in the Pituitary
doi: 10.1210/en.2018-00587
Figure Lengend Snippet: Immunoprecipitation of H3K27-acetylated (H3K27ac) chromatin in Pit-1/0 cells expressing Nr4a2 and/or Pou1f1. Pit-1/0 cells, which express neither Nr4a2 nor significant levels of Pou1f1, were transfected with Nr4a2-IRES-GFP, Pou1f1-IRES-GFP, or a 1:1 mixture of both expression vectors, and control cells were transfected with an empty IRES-GFP vector. Cells transfected with the 1:1 mixture of the Pou1f1 and Nr4a2 expression vectors express lower levels of each protein due to the concentration of each expression vector being halved during transfection to keep the total amount of DNA constant in each transfection. GFP+ cells were isolated by FACS and chromatin was isolated. ChIP was performed using an antibody that recognizes H3K27ac. Following ChIP, qRT-PCR was performed to assay the levels of H327 acetylation at the Gh promoter, the Prl promoter, and the MyoD promoter as a negative control. IgG controls (data not shown) were also included in this assay for all samples. In all cases, ChIP performed with IgG yielded <1% of input. *P < 0.05.
Article Snippet: Cell transfection assays The cDNA of Nupr1 was amplified from mouse pituitary cDNA. cDNAs for the other studied transcription factors were obtained from OriGene or Addgene and subcloned into an internal
Techniques: Immunoprecipitation, Expressing, Transfection, Control, Plasmid Preparation, Concentration Assay, Isolation, Quantitative RT-PCR, Negative Control